These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20489688)

  • 1. Association of serum cystatin C with pulse wave velocity, but not pressure wave reflection, in subjects with normal renal function or mild chronic kidney disease.
    Odaira M; Tomiyama H; Matsumoto C; Yamada J; Yoshida M; Shiina K; Nagata M; Yamashina A
    Am J Hypertens; 2010 Sep; 23(9):967-73. PubMed ID: 20489688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cystatin C is related to pulse wave velocity even in subjects with normal serum creatinine.
    Song SH; Kwak IS; Kim YJ; Lee HS; Rhee H; Lee DW; Kang YH; Kim SJ
    Hypertens Res; 2008 Oct; 31(10):1895-902. PubMed ID: 19015597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes.
    Macisaac RJ; Tsalamandris C; Thomas MC; Premaratne E; Panagiotopoulos S; Smith TJ; Poon A; Jenkins MA; Ratnaike SI; Power DA; Jerums G
    Diabet Med; 2007 Apr; 24(4):443-8. PubMed ID: 17388960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of various glomerular filtration rates estimating equations in patients with chronic kidney disease and diabetes.
    Li HX; Xu GB; Wang XJ; Zhang XC; Yang JM
    Chin Med J (Engl); 2010 Mar; 123(6):745-51. PubMed ID: 20368098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cystatin C and cardiovascular risk].
    Taglieri N; Koenig W; Kaski JC
    Ann Biol Clin (Paris); 2010; 68(5):517-29. PubMed ID: 20870574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is there a relationship between cystatin C and inflammatory status, oxidative stress and other cardiovascular risk factors in non-diabetic patients with chronic kidney disease?].
    Font R; Prats M; Gutiérrez C; Bardají A; Lalana M; Marsillach J; Camps J; Martínez Vea A
    Nefrologia; 2009; 29(3):228-35. PubMed ID: 19554056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical validity of renal function markers including serum cystatin C on chronic kidney disease classification].
    Suzuki Y; Matsushita K; Yoshida T; Sawabe Y; Nomura F
    Rinsho Byori; 2011 Apr; 59(4):345-51. PubMed ID: 21626875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C and blood pressure: results of 24 h ambulatory blood pressure monitoring.
    Mena C; Robles NR; de Prado JM; Gallego FG; Cidoncha A
    Eur J Intern Med; 2010 Jun; 21(3):185-90. PubMed ID: 20493420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of cystatin C-based glomerular filtration rate estimation formulae in chronic kidney disease].
    Li XL; Liang M; Yang XB
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):575-8. PubMed ID: 20335143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A newly estimated glomerular filtration rate is independently associated with arterial stiffness in Japanese patients.
    Nakagawa N; Takahashi F; Chinda J; Kobayashi M; Hayashi Y; Abe M; Saijo Y; Kikuchi K; Hasebe N
    Hypertens Res; 2008 Feb; 31(2):193-201. PubMed ID: 18360037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships among renal function loss within the normal to mildly impaired range, arterial stiffness, inflammation, and oxidative stress.
    Yoshida M; Tomiyama H; Yamada J; Koji Y; Shiina K; Nagata M; Yamashina A
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1118-24. PubMed ID: 17913969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.
    Linzbach S; Samigullin A; Yilmaz S; Tsioga M; Zeiher AM; Spyridopoulos I
    Am J Cardiol; 2009 Apr; 103(8):1128-33. PubMed ID: 19361601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C and long-term mortality among subjects with normal creatinine-based estimated glomerular filtration rates: NHANES III (Third National Health and Nutrition Examination Survey).
    Wu CK; Lin JW; Caffrey JL; Chang MH; Hwang JJ; Lin YS
    J Am Coll Cardiol; 2010 Nov; 56(23):1930-6. PubMed ID: 21109116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population.
    Delanaye P; Cavalier E; Saint-Remy A; Lutteri L; Krzesinski JM
    Scand J Clin Lab Invest; 2009; 69(3):344-9. PubMed ID: 19051098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients.
    Boudville N; Salama M; Jeffrey GP; Ferrari P
    Nephrol Dial Transplant; 2009 Sep; 24(9):2926-30. PubMed ID: 19506046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a new plasma cystatin C-based formula and the Modification of Diet in Renal Disease creatinine-based formula for determination of glomerular filtration rate.
    Sterner G; Björk J; Carlson J; Grubb A; Nyman U
    Scand J Urol Nephrol; 2009; 43(3):242-9. PubMed ID: 19291590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery disease.
    Ilyas B; Dhaun N; Markie D; Stansell P; Goddard J; Newby DE; Webb DJ
    QJM; 2009 Mar; 102(3):183-91. PubMed ID: 19129249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominance of traditional cardiovascular risk factors over renal function in predicting arterial stiffness in subjects with chronic kidney disease.
    Sengstock D; Sands RL; Gillespie BW; Zhang X; Kiser M; Eisele G; Vaitkevicius P; Kuhlmann M; Levin NW; Hinderliter A; Rajagopalan S; Saran R
    Nephrol Dial Transplant; 2010 Mar; 25(3):853-61. PubMed ID: 19854848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.